Compile Data Set for Download or QSAR
Found 307 Enz. Inhib. hit(s) with Target = 'Serine/threonine-protein kinase 17A'
TargetSerine/threonine-protein kinase 17A(Homo sapiens (Human))TBA
LigandPNGBDBM50585203(CHEMBL5085430)copy SMILES
Affinity DataIC50: 4.5nMAssay Description:Displacement of tracer K9 from NLuc fused DRAK1 (unknown origin) expressed in HEK293 cells by NanoBRET assayMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q27S7SNDPubMed
TargetSerine/threonine-protein kinase 17A(Homo sapiens (Human))TBA
LigandPNGBDBM50274640(CHEMBL4126445)copy SMILEScopy InChI
Affinity DataIC50: 10nMAssay Description:Inhibition of recombinant human full length GST-tagged DRAK1 expressed in baculovirus expression systemMore data for this Ligand-Target Pair
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q27M0BFZPubMed
TargetSerine/threonine-protein kinase 17A(Homo sapiens (Human))TBA
LigandPNGBDBM441855(US10647686, Example (3))copy SMILEScopy InChI
Affinity DataIC50: 11nMAssay Description:To measure the DRAK1 and DRAK2 activity, the substrate MRCL3 peptide and ATP were mixed with the enzymes. After an appropriate period of time, the re...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
BindingDB Entry DOI: 10.7270/Q2MS3WSBUS Patent
TargetSerine/threonine-protein kinase 17A(Homo sapiens (Human))TBA
LigandPNGBDBM50166076(CHEMBL3799585)copy SMILEScopy InChI
Affinity DataIC50: 12nMAssay Description:Inhibition of DRAK1 (unknown origin)More data for this Ligand-Target Pair
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q2N29ZTZPubMed
TargetSerine/threonine-protein kinase 17A(Homo sapiens (Human))TBA
LigandPNGBDBM50154342(CHEMBL3774448)copy SMILEScopy InChI
Affinity DataIC50: 13nMAssay Description:Inhibition of STK17A (unknown origin)More data for this Ligand-Target Pair
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q2GF0WC4PubMed
TargetSerine/threonine-protein kinase 17A(Homo sapiens (Human))TBA
LigandPNGBDBM441866(US10647686, Example (13))copy SMILEScopy InChI
Affinity DataIC50: 14nMAssay Description:To measure the DRAK1 and DRAK2 activity, the substrate MRCL3 peptide and ATP were mixed with the enzymes. After an appropriate period of time, the re...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
BindingDB Entry DOI: 10.7270/Q2MS3WSBUS Patent
TargetSerine/threonine-protein kinase 17A(Homo sapiens (Human))TBA
LigandPNGBDBM441876(US10647686, Example (23))copy SMILEScopy InChI
Affinity DataIC50: 15nMAssay Description:To measure the DRAK1 and DRAK2 activity, the substrate MRCL3 peptide and ATP were mixed with the enzymes. After an appropriate period of time, the re...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
BindingDB Entry DOI: 10.7270/Q2MS3WSBUS Patent
TargetSerine/threonine-protein kinase 17A(Homo sapiens (Human))TBA
LigandPNGBDBM50520157(CHEMBL4436188)copy SMILEScopy InChI
Affinity DataIC50: 15nMAssay Description:Inhibition of wild-type human partial length DRAK1 (R32 to E363 residues) expressed in bacterial expression system by Kinomescan methodMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q2CN7795PubMed
TargetSerine/threonine-protein kinase 17A(Homo sapiens (Human))TBA
LigandPNGBDBM50606011(CHEMBL5191892)copy SMILES
Affinity DataIC50: 15nMMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q2NC6587PubMed
TargetSerine/threonine-protein kinase 17A(Homo sapiens (Human))TBA
LigandPNGBDBM441873(US10647686, Example (20))copy SMILEScopy InChI
Affinity DataIC50: 16nMAssay Description:To measure the DRAK1 and DRAK2 activity, the substrate MRCL3 peptide and ATP were mixed with the enzymes. After an appropriate period of time, the re...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
BindingDB Entry DOI: 10.7270/Q2MS3WSBUS Patent
TargetSerine/threonine-protein kinase 17A(Homo sapiens (Human))TBA
LigandPNGBDBM441862(US10647686, Example (9))copy SMILEScopy InChI
Affinity DataIC50: 19nMAssay Description:To measure the DRAK1 and DRAK2 activity, the substrate MRCL3 peptide and ATP were mixed with the enzymes. After an appropriate period of time, the re...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
BindingDB Entry DOI: 10.7270/Q2MS3WSBUS Patent
TargetSerine/threonine-protein kinase 17A(Homo sapiens (Human))TBA
LigandPNGBDBM441878(US10647686, Example (24))copy SMILEScopy InChI
Affinity DataIC50: 19nMAssay Description:To measure the DRAK1 and DRAK2 activity, the substrate MRCL3 peptide and ATP were mixed with the enzymes. After an appropriate period of time, the re...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
BindingDB Entry DOI: 10.7270/Q2MS3WSBUS Patent
TargetSerine/threonine-protein kinase 17A(Homo sapiens (Human))TBA
LigandPNGBDBM441882(US10647686, Example (26))copy SMILEScopy InChI
Affinity DataIC50: 19nMAssay Description:To measure the DRAK1 and DRAK2 activity, the substrate MRCL3 peptide and ATP were mixed with the enzymes. After an appropriate period of time, the re...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
BindingDB Entry DOI: 10.7270/Q2MS3WSBUS Patent
TargetSerine/threonine-protein kinase 17A(Homo sapiens (Human))TBA
LigandPNGBDBM441874(US10647686, Example (21))copy SMILEScopy InChI
Affinity DataIC50: 21nMAssay Description:To measure the DRAK1 and DRAK2 activity, the substrate MRCL3 peptide and ATP were mixed with the enzymes. After an appropriate period of time, the re...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
BindingDB Entry DOI: 10.7270/Q2MS3WSBUS Patent
TargetSerine/threonine-protein kinase 17A(Homo sapiens (Human))TBA
LigandPNGBDBM50166251(CHEMBL3799389)copy SMILEScopy InChI
Affinity DataIC50: 21nMAssay Description:Inhibition of DRAK1 (unknown origin)More data for this Ligand-Target Pair
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q2N29ZTZPubMed
TargetSerine/threonine-protein kinase 17A(Homo sapiens (Human))TBA
LigandPNGBDBM441881(US10647686, Example (25))copy SMILEScopy InChI
Affinity DataIC50: 22nMAssay Description:To measure the DRAK1 and DRAK2 activity, the substrate MRCL3 peptide and ATP were mixed with the enzymes. After an appropriate period of time, the re...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
BindingDB Entry DOI: 10.7270/Q2MS3WSBUS Patent
TargetSerine/threonine-protein kinase 17A(Homo sapiens (Human))TBA
LigandPNGBDBM441872(US10647686, Example (19) | US10647686, Example 19)copy SMILEScopy InChI
Affinity DataIC50: 23nMAssay Description:To measure the DRAK1 and DRAK2 activity, the substrate MRCL3 peptide and ATP were mixed with the enzymes. After an appropriate period of time, the re...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
BindingDB Entry DOI: 10.7270/Q2MS3WSBUS Patent
TargetSerine/threonine-protein kinase 17A(Homo sapiens (Human))TBA
LigandPNGBDBM441870(US10647686, Example (17))copy SMILEScopy InChI
Affinity DataIC50: 23nMAssay Description:To measure the DRAK1 and DRAK2 activity, the substrate MRCL3 peptide and ATP were mixed with the enzymes. After an appropriate period of time, the re...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
BindingDB Entry DOI: 10.7270/Q2MS3WSBUS Patent
TargetSerine/threonine-protein kinase 17A(Homo sapiens (Human))TBA
LigandPNGBDBM441872(US10647686, Example (19) | US10647686, Example 19)copy SMILEScopy InChI
Affinity DataIC50: 23nMAssay Description:To measure the DRAK1 and DRAK2 activity, the substrate MRCL3 peptide and ATP were mixed with the enzymes. After an appropriate period of time, the re...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
BindingDB Entry DOI: 10.7270/Q2MS3WSBUS Patent
TargetSerine/threonine-protein kinase 17A(Homo sapiens (Human))TBA
LigandPNGBDBM441872(US10647686, Example (19) | US10647686, Example 19)copy SMILEScopy InChI
Affinity DataIC50: 23nMAssay Description:To measure the DRAK1 and DRAK2 activity, the substrate MRCL3 peptide and ATP were mixed with the enzymes. After an appropriate period of time, the re...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
BindingDB Entry DOI: 10.7270/Q2MS3WSBUS Patent
TargetSerine/threonine-protein kinase 17A(Homo sapiens (Human))TBA
LigandPNGBDBM441875(US10647686, Example (22))copy SMILEScopy InChI
Affinity DataIC50: 24nMAssay Description:To measure the DRAK1 and DRAK2 activity, the substrate MRCL3 peptide and ATP were mixed with the enzymes. After an appropriate period of time, the re...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
BindingDB Entry DOI: 10.7270/Q2MS3WSBUS Patent
TargetSerine/threonine-protein kinase 17A(Homo sapiens (Human))TBA
LigandPNGBDBM50166271(CHEMBL3798563)copy SMILEScopy InChI
Affinity DataIC50: 24nMAssay Description:Inhibition of DRAK1 (unknown origin)More data for this Ligand-Target Pair
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q2N29ZTZPubMed
TargetSerine/threonine-protein kinase 17A(Homo sapiens (Human))TBA
LigandPNGBDBM441858(US10647686, Example (6))copy SMILEScopy InChI
Affinity DataIC50: 24nMAssay Description:To measure the DRAK1 and DRAK2 activity, the substrate MRCL3 peptide and ATP were mixed with the enzymes. After an appropriate period of time, the re...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
BindingDB Entry DOI: 10.7270/Q2MS3WSBUS Patent
TargetSerine/threonine-protein kinase 17A(Homo sapiens (Human))TBA
LigandPNGBDBM50166260(CHEMBL3799505)copy SMILEScopy InChI
Affinity DataIC50: 24nMAssay Description:Inhibition of DRAK1 (unknown origin)More data for this Ligand-Target Pair
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q2N29ZTZPubMed
TargetSerine/threonine-protein kinase 17A(Homo sapiens (Human))TBA
LigandPNGBDBM50520152(CHEMBL4594167 | US10894784, Example 150.02)copy SMILEScopy InChI
Affinity DataIC50: 25nMAssay Description:Inhibition of wild-type human partial length DRAK1 (R32 to E363 residues) expressed in bacterial expression system by Kinomescan methodMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q2CN7795PubMed
TargetSerine/threonine-protein kinase 17A(Homo sapiens (Human))TBA
LigandPNGBDBM441868(US10647686, Example (15))copy SMILEScopy InChI
Affinity DataIC50: 26nMAssay Description:To measure the DRAK1 and DRAK2 activity, the substrate MRCL3 peptide and ATP were mixed with the enzymes. After an appropriate period of time, the re...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
BindingDB Entry DOI: 10.7270/Q2MS3WSBUS Patent
TargetSerine/threonine-protein kinase 17A(Homo sapiens (Human))TBA
LigandPNGBDBM441863(US10647686, Example (10))copy SMILEScopy InChI
Affinity DataIC50: 26nMAssay Description:To measure the DRAK1 and DRAK2 activity, the substrate MRCL3 peptide and ATP were mixed with the enzymes. After an appropriate period of time, the re...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
BindingDB Entry DOI: 10.7270/Q2MS3WSBUS Patent
TargetSerine/threonine-protein kinase 17A(Homo sapiens (Human))TBA
LigandPNGBDBM441854(US10647686, Example (2))copy SMILEScopy InChI
Affinity DataIC50: 26nMAssay Description:To measure the DRAK1 and DRAK2 activity, the substrate MRCL3 peptide and ATP were mixed with the enzymes. After an appropriate period of time, the re...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
BindingDB Entry DOI: 10.7270/Q2MS3WSBUS Patent
TargetSerine/threonine-protein kinase 17A(Homo sapiens (Human))TBA
LigandPNGBDBM441904(US10647686, Comparative Example 6)copy SMILEScopy InChI
Affinity DataIC50: 27nMAssay Description:To measure the DRAK1 and DRAK2 activity, the substrate MRCL3 peptide and ATP were mixed with the enzymes. After an appropriate period of time, the re...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
BindingDB Entry DOI: 10.7270/Q2MS3WSBUS Patent
TargetSerine/threonine-protein kinase 17A(Homo sapiens (Human))TBA
LigandPNGBDBM441904(US10647686, Comparative Example 6)copy SMILEScopy InChI
Affinity DataIC50: 27nMAssay Description:To measure the DRAK1 and DRAK2 activity, the substrate MRCL3 peptide and ATP were mixed with the enzymes. After an appropriate period of time, the re...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
BindingDB Entry DOI: 10.7270/Q2MS3WSBUS Patent
TargetSerine/threonine-protein kinase 17A(Homo sapiens (Human))TBA
LigandPNGBDBM50520150(CHEMBL4566796)copy SMILEScopy InChI
Affinity DataIC50: 30nMAssay Description:Inhibition of wild-type human partial length DRAK1 (R32 to E363 residues) expressed in bacterial expression system by Kinomescan methodMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q2CN7795PubMed
TargetSerine/threonine-protein kinase 17A(Homo sapiens (Human))TBA
LigandPNGBDBM2579((2S,3R,4R,6R)-3-methoxy-2-methyl-4-(methylamino)-2...)copy SMILEScopy InChI
Affinity DataIC50: 30.4nMAssay Description:Inhibition of human DRAK1 using KKLNRTLSFAEPG as substrate by [gamma-33P]-ATP assayMore data for this Ligand-Target Pair
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q2W380MTPubMed
TargetSerine/threonine-protein kinase 17A(Homo sapiens (Human))TBA
LigandPNGBDBM50606014(CHEMBL5193635)copy SMILES
Affinity DataIC50: 31nMMore data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q2NC6587PubMed
TargetSerine/threonine-protein kinase 17A(Homo sapiens (Human))TBA
LigandPNGBDBM441898(US10647686, Example (41))copy SMILEScopy InChI
Affinity DataIC50: 31nMAssay Description:To measure the DRAK1 and DRAK2 activity, the substrate MRCL3 peptide and ATP were mixed with the enzymes. After an appropriate period of time, the re...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
BindingDB Entry DOI: 10.7270/Q2MS3WSBUS Patent
TargetSerine/threonine-protein kinase 17A(Homo sapiens (Human))TBA
LigandPNGBDBM2579((2S,3R,4R,6R)-3-methoxy-2-methyl-4-(methylamino)-2...)copy SMILEScopy InChI
Affinity DataIC50: 31.4nMAssay Description:Inhibition of human DRAK1 using KKLNRTLSFAEPG as substrate by [gamma-33P]-ATP assayMore data for this Ligand-Target Pair
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q2DJ5KB8PubMed
TargetSerine/threonine-protein kinase 17A(Homo sapiens (Human))TBA
LigandPNGBDBM441905(US10647686, Example 1)copy SMILEScopy InChI
Affinity DataIC50: 32nMAssay Description:To measure the DRAK1 and DRAK2 activity, the substrate MRCL3 peptide and ATP were mixed with the enzymes. After an appropriate period of time, the re...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
BindingDB Entry DOI: 10.7270/Q2MS3WSBUS Patent
TargetSerine/threonine-protein kinase 17A(Homo sapiens (Human))TBA
LigandPNGBDBM50166077(CHEMBL513703)copy SMILEScopy InChI
Affinity DataIC50: 32nMAssay Description:Inhibition of DRAK1 (unknown origin)More data for this Ligand-Target Pair
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q2N29ZTZPubMed
TargetSerine/threonine-protein kinase 17A(Homo sapiens (Human))TBA
LigandPNGBDBM441869(US10647686, Example (16))copy SMILEScopy InChI
Affinity DataIC50: 34nMAssay Description:To measure the DRAK1 and DRAK2 activity, the substrate MRCL3 peptide and ATP were mixed with the enzymes. After an appropriate period of time, the re...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
BindingDB Entry DOI: 10.7270/Q2MS3WSBUS Patent
TargetSerine/threonine-protein kinase 17A(Homo sapiens (Human))TBA
LigandPNGBDBM441895(US10647686, Example (38))copy SMILEScopy InChI
Affinity DataIC50: 35nMAssay Description:To measure the DRAK1 and DRAK2 activity, the substrate MRCL3 peptide and ATP were mixed with the enzymes. After an appropriate period of time, the re...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
BindingDB Entry DOI: 10.7270/Q2MS3WSBUS Patent
TargetSerine/threonine-protein kinase 17A(Homo sapiens (Human))TBA
LigandPNGBDBM441871(US10647686, Example (18))copy SMILEScopy InChI
Affinity DataIC50: 35nMAssay Description:To measure the DRAK1 and DRAK2 activity, the substrate MRCL3 peptide and ATP were mixed with the enzymes. After an appropriate period of time, the re...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
BindingDB Entry DOI: 10.7270/Q2MS3WSBUS Patent
TargetSerine/threonine-protein kinase 17A(Homo sapiens (Human))TBA
LigandPNGBDBM441867(US10647686, Example (14))copy SMILEScopy InChI
Affinity DataIC50: 37nMAssay Description:To measure the DRAK1 and DRAK2 activity, the substrate MRCL3 peptide and ATP were mixed with the enzymes. After an appropriate period of time, the re...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
BindingDB Entry DOI: 10.7270/Q2MS3WSBUS Patent
TargetSerine/threonine-protein kinase 17A(Homo sapiens (Human))TBA
LigandPNGBDBM441905(US10647686, Example 1)copy SMILEScopy InChI
Affinity DataIC50: 38nMAssay Description:To measure the DRAK1 and DRAK2 activity, the substrate MRCL3 peptide and ATP were mixed with the enzymes. After an appropriate period of time, the re...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
BindingDB Entry DOI: 10.7270/Q2MS3WSBUS Patent
TargetSerine/threonine-protein kinase 17A(Homo sapiens (Human))TBA
LigandPNGBDBM441853(US10647686, Example (1))copy SMILEScopy InChI
Affinity DataIC50: 38nMAssay Description:To measure the DRAK1 and DRAK2 activity, the substrate MRCL3 peptide and ATP were mixed with the enzymes. After an appropriate period of time, the re...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
BindingDB Entry DOI: 10.7270/Q2MS3WSBUS Patent
TargetSerine/threonine-protein kinase 17A(Homo sapiens (Human))TBA
LigandPNGBDBM50111572(CHEMBL3605057)copy SMILEScopy InChI
Affinity DataIC50: 43nMAssay Description:Displacement of tracer K9 from NLuc fused DRAK1 (unknown origin) expressed in HEK293 cells by NanoBRET assayMore data for this Ligand-Target Pair
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q27S7SNDPubMed
TargetSerine/threonine-protein kinase 17A(Homo sapiens (Human))TBA
LigandPNGBDBM441864(US10647686, Example (11))copy SMILEScopy InChI
Affinity DataIC50: 44nMAssay Description:To measure the DRAK1 and DRAK2 activity, the substrate MRCL3 peptide and ATP were mixed with the enzymes. After an appropriate period of time, the re...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
BindingDB Entry DOI: 10.7270/Q2MS3WSBUS Patent
TargetSerine/threonine-protein kinase 17A(Homo sapiens (Human))TBA
LigandPNGBDBM441897(US10647686, Example (40) | US10647686, Example 40)copy SMILEScopy InChI
Affinity DataIC50: 47nMAssay Description:To measure the DRAK1 and DRAK2 activity, the substrate MRCL3 peptide and ATP were mixed with the enzymes. After an appropriate period of time, the re...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
BindingDB Entry DOI: 10.7270/Q2MS3WSBUS Patent
TargetSerine/threonine-protein kinase 17A(Homo sapiens (Human))TBA
LigandPNGBDBM441897(US10647686, Example (40) | US10647686, Example 40)copy SMILEScopy InChI
Affinity DataIC50: 47nMAssay Description:To measure the DRAK1 and DRAK2 activity, the substrate MRCL3 peptide and ATP were mixed with the enzymes. After an appropriate period of time, the re...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails
BindingDB Entry DOI: 10.7270/Q2MS3WSBUS Patent
TargetSerine/threonine-protein kinase 17A(Homo sapiens (Human))TBA
LigandPNGBDBM50166121(CHEMBL3797480)copy SMILEScopy InChI
Affinity DataIC50: 51nMAssay Description:Inhibition of DRAK1 (unknown origin)More data for this Ligand-Target Pair
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q2N29ZTZPubMed
TargetSerine/threonine-protein kinase 17A(Homo sapiens (Human))TBA
LigandPNGBDBM2579((2S,3R,4R,6R)-3-methoxy-2-methyl-4-(methylamino)-2...)copy SMILEScopy InChI
Affinity DataIC50: 54nMMore data for this Ligand-Target Pair
In DepthDetails Article
BindingDB Entry DOI: 10.7270/Q2NC6587PubMed
Displayed 1 to 50 (of 307 total ) | Next | Last >>
Jump to: